Stay updated with breaking news from 35mg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
More than half of the patients demonstrated remission of depression at 18 months, after a single dose of 25mg investigational COMP360 psilocybin with psychological supportOpen label phase 2 study,... | May 26, 2023
- Data readout will focus on safety and seizure frequency results for up to 16 patients who received three doses of 45mg of STK-001 - - Company plans to initiate a pivotal study... | May 4, 2023
Taiho Pharmaceutical Obtains Approval to Manufacture and Market NK1 Receptor Antagonist Arokaris I.V. Infusion 235mg in Japan Tokyo, Japan, and Lugano, Switzerland March 28, 2022
With 75mg the planned dose for further development Ensovibep continues to maintain potent in vitro pan-variant activity against all variants of concern identified so... | January 10, 2022